UK markets closed
  • FTSE 100

    +81.64 (+1.04%)
  • FTSE 250

    -21.23 (-0.10%)
  • AIM

    +1.03 (+0.12%)

    -0.0042 (-0.37%)

    -0.0173 (-1.41%)

    -196.76 (-1.00%)
  • CMC Crypto 200

    -1.43 (-0.27%)
  • S&P 500

    -43.28 (-1.04%)
  • DOW

    -127.93 (-0.38%)

    -2.65 (-3.49%)

    -50.40 (-2.63%)
  • NIKKEI 225

    +107.41 (+0.39%)

    -297.89 (-1.36%)
  • DAX

    -32.76 (-0.21%)
  • CAC 40

    +67.67 (+0.94%)

The Global Osteosynthesis Devices Market size is expected to reach $14.2 billion by 2028, rising at a market growth of 8.0% CAGR during the forecast period


One of the most often used surgical methods in orthopedics, including both elective orthopedics and traumatology, is osteosynthesis. It entails the joining of two or more bone fragments after they have first achieved correct alignment.

New York, Jan. 25, 2023 (GLOBE NEWSWIRE) -- announces the release of the report "Global Osteosynthesis Devices Market Size, Share & Industry Trends Analysis Report By Type, By Material, By Fracture Type, By Regional Outlook and Forecast, 2022 - 2028" -
In order to keep the union mechanically stable until the biological process of fracture healing has rebuilt the bone segment as a single unit, screws, nails, plates, and other mechanical devices are used.

Therefore, materials used in osteosynthesis must have biological properties that can keep them in apposition with the bone for a period of time, during which they must not hinder or interfere with the bone process of healing and, if possible, must support and encourage it. They must also have mechanical properties sufficient to take the load on the injured bone segment.

Positive demographic trends, continuous product innovation, an increase in physician skill, enhanced value-based payment methods, and site-of-service flexibility will all continue to favorably impact the market. For instance, the financial framework for osteosynthesis device treatment has undergone significant recent revisions, notably with regard to site-of-service pricing.

The need for treatments utilizing osteosynthesis devices will rise as a result of injuries incurred by drivers and passengers in car accidents. As more individuals use motorbikes as their major form of transportation due to their affordability, injuries from motorcycle crashes will also have an impact on the market.

COVID-19 Impact Analysis

The COVID-19 pandemic has done a great deal of damage to the market for osteosynthesis devices. The spread of the COVID-19 virus caused a significant fall in the sales of surgical equipment during the early stages of the pandemic. In order to maximize the amount of hospital space available for COVID-19 patients during the epidemic, all elective surgeries were also delayed or canceled. Due to the new coronavirus’s extensive circulation and the lockdown measures that followed it, many patients have been disallowed access to bariatric surgery.

Market Growth Factors

The Shift Toward Minimally Invasive Spine Procedures

Physicians are increasingly adopting minimally invasive spine procedures to treat vertebral compression fractures and other spinal-related problems. It is because these procedures help in stabilizing the vertebral bones & spinal joints and/or release pressure being applied to the spinal nerves, which generally lead to the conditions like bone spurs, spinal instability, scoliosis, herniated discs, or spinal tumors. Thereby, these factors would drive the demand for the Osteosynthesis Devices Market.

Aging Population Raises The Risk Of Osteoarthritis

The large growth in the number of elderly people and osteoarthritis patients is leading to an increase in surgical procedures performed globally. Chronic illnesses that necessitate several operations are more likely to occur in adults 60 years of age and older. In low-, middle-, and high-income nations, non-communicable illnesses are anticipated to represent more than 87% of cases by 2030, which would increase the demand for surgery. The prevalence of such ailments is driving the market for osteosynthesis devices.

Market Restraining Factors

Osteosynthesis complications such as implant-associated infections (iai) continue to be difficult.

In orthopedics and traumatology, infection is still a significant postoperative consequence. Infection prevention may depend heavily on the implant’s design, material, and implantation method. These infections are frequently brought on by bacteria that produce biofilms. The use of surgical debridement and antibiotics is required by therapeutic algorithms. The existence of bacterial biofilms, which are frequently linked to slow-growing microorganisms, low bacterial loads, prior antibiotic treatments, and potential intra-operative contamination, make the microbiological detection of implant-related illnesses difficult.

Type Outlook

Based on type, the osteosynthesis devices market is divided into Internal and External segments. Internal fixation equipment generated the largest market share in 2021 due to being the most frequently used surgical procedure worldwide. Metal plates, nails, and screws are the most often used internal fixation methods for treating fractures. These devices assist in retaining the fractured bone together by stabilizing and supporting it.

Material Outlook

Based on material, the Osteosynthesis Devices Market is divided into Degradable and Non-degradable. The degradable segment showcased the significant revenue share in the market in 2021. Devices made of biodegradable polymers are effective for osteosynthesis in instances involving minor to no load bearing. To increase their utility, biodegradable devices must improve their mechanical characteristics and degrading behaviour.

Fracture Type Outlook

Based on the fracture type, the market is categorized into the skull, facial bones, sternum or one or more ribs, or both, clavicle, scapula, or humerus, radius or ulna, or both, hand, wrist, or any other distal portion of the hand, vertebral column, pelvis, hip, femur—other than the femoral neck—patella, tibia, fibula, or ankle, and any foot bones other than the ankle. Clavicle, Scapula, or Humerus accounted for the considerable revenue share in the market in 2021. In the fifth week of foetal development, the clavicle becomes the first bone in the human body to undergo intramembranous ossification directly from mesenchyme. The clavicle has a medial and lateral epiphysis, like other long bones, but no clearly defined medullary cavity.

Regional Outlook

Based on geography, the Osteosynthesis Devices Market is divided into North America, Europe, Asia Pacific, and LAMEA. In 2021, North America led the market and generated the most significant revenue share due to considerable government initiatives, the introduction of new products, and significant R&D investments. With the highest revenue share in North America, the United States is the most lucrative and most significant market for osteosynthesis equipment due to rising healthcare costs and the concentration of the country’s primary orthopedic device industry.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DePuy Synthes, Inc. (J & J Company), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, Medtronic PLC, Olympus Corporation, Globus Medical, Inc., Arthrex, Inc., Lepu Medical Technology Co., Ltd, and Life Spine, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

• Internal

o Screws & Plates

o Wires & Pins

o Intramedullary Rods & Nails

o Spinal Fixation Devices

• External

o Fracture Fixation

o Bone Lengthening

By Material

• Nondegradable

• Degradable

By Fracture Type

• Patella, Tibia or Fibula, or Ankle

• Hand & Wrist

• Foot Bones & Vertebral Column

• Hip

• Pelvis

• Clavicle, Scapula, or Humerus

• Femur

• Radius or ulna

• Others

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• DePuy Synthes, Inc. (J & J Company)

• Stryker Corporation

• Zimmer Biomet Holdings, Inc.

• Smith & Nephew PLC

• Medtronic PLC

• Olympus Corporation

• Globus Medical, Inc.

• Arthrex, Inc.

• Lepu Medical Technology Co., Ltd

• Life Spine, Inc.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001